|
Palladium Group, Inc.
|
|
Strategy Execution in the Pharmaceutical and Life Sciences Industries
|
|
Pharmaceutical and life sciences companies face a multitude of challenges, from patent expirations and regulatory changes to pricing pressures and the need for new commercial approaches. A coherent strategy and disciplined execution are more important than ever. In this Balanced Scorecard Report article, Barnaby Donlon examines some of the strategies these companies are pursuing to excel in their mercilessly competitive marketplaces, showing how strategy maps and strategic themes, along with an Office of Strategy Management, are instrumental at every stage of strategy execution.
|
Please enter your information in the form below to access our free content.
Note: * indicates mandatory fields.
|
|
|
|
|